Lv1
70 积分 2025-07-17 加入
Osimertinib: First Global Approval
30天前
已完结
阿尔茨海默病脑健康营养干预专家共识
5个月前
已完结
Table: Amyloid-Directed Antibodies for Alzheimer's Disease
5个月前
已关闭
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins
5个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
5个月前
已完结
Targeted Immunotherapy for Autoimmune Disease
8个月前
已完结
To platform or not to platform: Strategic considerations for antibody formulation in early clinical development
9个月前
已完结
Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides
9个月前
已完结
Safety screening in early drug discovery: An optimized assay panel
11个月前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
11个月前
已完结
皖公网安备34019202002308
